Livzon Mabpharm
Latest round
- Series A
Last raised
- Jun 2018
Total raised
- $148M
Investors
- 2
About Livzon Mabpharm
Livzon Mabpharm, Inc.Founded in 2010 in Zhuhai, China, Livzon Mabpharm, Inc. specializes in biopharmaceutical development. The company has not undergone any major pivots or changes in strategy since its inception.Livzon Mabpharm specializes in the development and production of innovative biopharmaceutical products, focusing primarily on monoclonal antibodies and other biologics. Their flagship offerings are designed to address a range of therapeutic areas, including oncology, autoimmune disorders, and infectious diseases.Livzon Mabpharm's revenue model is structured around direct sales of its biopharmaceutical products to healthcare institutions and partnerships with distributors. In the coming years, the company is targeting the launch of several new innovative monoclonal antibodies aimed at addressing unmet medical needs in oncology and autoimmune disorders. Additionally, Livzon Mabpharm aims to expand its market presence in Europe and North America by 2022, enhancing its distribution networks and partnerships in these critical regions.
Who invested in Livzon Mabpharm
2 investors across 1 round
See all investors in Livzon Mabpharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 26, 2018
Amount
$148M
Investors
Questions about Livzon Mabpharm
Who invested in Livzon Mabpharm?
Livzon Mabpharm has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Livzon Mabpharm raised?
Livzon Mabpharm has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Livzon Mabpharm last raise money?
Livzon Mabpharm's most recent round on record is a Series A, in Jun 2018.
What does Livzon Mabpharm do?
Livzon Mabpharm is a pharmaceuticals company.
Where is Livzon Mabpharm headquartered?
Livzon Mabpharm is headquartered in Zhuhai, China.
Which VCs invest in companies like Livzon Mabpharm?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Livzon Mabpharm's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Livzon Mabpharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.